CardiacWire

JANUARY 31, 2025

While theres no one answer for a specific patient group, the AHAs biggest CVD risk culprits should be pretty familiar – obesity, smoking/tobacco use, and sedentary behavior. From 2017 to 2020, adult obesity prevalence in the U.S. was 41.8%, while obesity-related CV deaths tripled from 1999 to 2020 (2.2

Cardiovascular Disease 59

Cardiovascular Disease Obesity Heart Disease Public Health 59

Medical Xpress - Cardiology

DECEMBER 18, 2024

Cardiovascular disease (CVD) is a critical public health concern, with risk factors such as high blood pressure, abnormal blood sugar levels, elevated cholesterol, and obesity beginning in childhood.

Blood Pressure 75

Blood Pressure Public Health Cholesterol Obesity 75

DAIC

AUGUST 15, 2024

13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and published in JAMA Cardiology. School of Public Health at UT Southwestern. Ann Marie Navar, M.D., population.

Heart Disease 105

Heart Disease Research Cholesterol Public Health 105

Cardiology Update

JANUARY 24, 2024

Growing Global Burden of Cardiometabolic Risks: The 2023 World Obesity Atlas projects a significant rise in global overweight and obesity levels by 2035, leading to a surge in diabetes cases. The findings have significant implications for clinical and public health practice and research.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

Circulation

JANUARY 24, 2024

The AHA strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Stroke Strokes 81

DAIC

MARCH 8, 2024

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111

Obesity Heart Disease Heart Attack Heart attacks 111

Dr. Malcolm Kendrick

OCTOBER 30, 2024

I, Dr Malcolm Kendrick, with or without other co-conspirators, would be accused of spreading misinformation about cholesterol and statins. The hypothesis that a raised cholesterol level causes heart disease [atherosclerotic cardiovascular disease (ASCVD)] is possibly the single most powerful idea in medicine. With thousands dying.

Cholesterol 145

Cholesterol Article Research Diet 145